C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED is a TAMIL NADU based PRIVATE LIMITED company registered on 16-OCT-2018 at the Ministry of Corporate Affairs (MCA). The Corporate Identification Number (CIN) is U74999TN2018PTC125295 and registration number is 125295.
It is classified as COMPANY LIMITED BY SHARES and registered under the Registrar of Companies , India. Authorised share capital is ₹1000 and paid-up capital is ₹10000. It operates in NA activities.
Its last AGM was held on and the balance sheet was last filed on . C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED has 2 director(s): PADMANABHAN MAHALINGAM; KARTHIK KRISHNA;
Company Basic Details
Company Name
C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED
CIN
U74999TN2018PTC125295
Registration No.
125295
Company Status
ACTIVE
RoC
Company Activity
NA
Category
COMPANY LIMITED BY SHARES
Sub Category
NON-GOVERNMENT
Company Class
PRIVATE
Registration Date
16 OCT 2018
Authorised Capital
₹ 1000
Paid-Up Capital
₹ 10000
Last AGM Date
Last Balance Sheet
Contact Details
State
District
PIN Code
Country
India
Address
COMPANY C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED THIRUVANMIYUR T4, 7TH STREET, DR V.S.I ESTATE PHASE II
Email
venkat.s@dsnl.in
Director Details
| DIN | Director Name | Designation | Appointment Date |
|---|---|---|---|
| 00115671 | PADMANABHAN MAHALINGAM | Director | 16/10/2018 |
| 06993503 | KARTHIK KRISHNA | Director | 16/10/2018 |
Details Updated by Company
Contact Person
Business Email
Business Address
Brand / Short Name
Frequently Asked Questions — C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED
The Corporate Identification Number (CIN) of C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED is U74999TN2018PTC125295.
C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED was incorporated on 16 OCT 2018 in TAMIL NADU.
The current status of C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED is ACTIVE.
The registered office address of C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED is COMPANY C3WARE MULTICALL TECHNOLOGIES PRIVATE LIMITED THIRUVANMIYUR T4, 7TH STREET, DR V.S.I ESTATE PHASE II.